Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
about
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenesActivity of telithromycin and comparators against bacterial pathogens isolated from 1,336 patients with clinically diagnosed acute sinusitisAntibiotic resistance in primary care in Austria - a systematic review of scientific and grey literatureBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Can antibiotic prescriptions in respiratory tract infections be improved? A cluster-randomized educational intervention in general practice--the Prescription Peer Academic Detailing (Rx-PAD) Study [NCT00272155]Increase in pneumococcus macrolide resistance, United States.Risk factors associated with colonization by pneumococci with reduced susceptibility to fluoroquinolones in adult outpatients.Molecular epidemiology of macrolide-resistant Streptococcus pneumoniae isolates in Europe.Trends in drug resistance, serotypes, and molecular types of Streptococcus pneumoniae colonizing preschool-age children attending day care centers in Lisbon, Portugal: a summary of 4 years of annual surveillanceMolecular epidemiology of macrolide-resistant isolates of Streptococcus pneumoniae collected from blood and respiratory specimens in Norway.Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003.Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in GermanyEmergence of a Streptococcus pneumoniae clinical isolate highly resistant to telithromycin and fluoroquinolones.Novel antibacterial class.Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implications for treatment policy and vaccine formulation.Phenotypic and molecular characterization of tetracycline- and erythromycin-resistant strains of Streptococcus pneumoniae.Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in GermanyPneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in GermanyAntibacterial activity and mechanism of action of a novel anilinouracil-fluoroquinolone hybrid compound.A prescription event monitoring study on the utility of garenoxacin, a newer fluoroquinolone in India.Genotypes and related factors reflecting macrolide resistance in pneumococcal pneumonia infections in Japan.Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistanceHidden epidemic of macrolide-resistant pneumococci.Update on treatment guidelines for acute bacterial sinusitis.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Management of acute bacterial rhinosinusitis: current issues and future perspectives.Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4The efficacy of cefdinir in acute bacterial rhinosinusitis.High prevalence of the ermB gene among erythromycin-resistant streptococcus pneumoniae isolates in Germany during the winter of 2000-2001 and in vitro activity of telithromycin.Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.Seasonality of antibiotic-resistant streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?Role of gemifloxacin in community-acquired pneumonia.Genomic characterization of ciprofloxacin resistance in a laboratory-derived mutant and a clinical isolate of Streptococcus pneumoniae.Curbing the menace of antimicrobial resistance in developing countriesIn vitro antimicrobial susceptibilities of Streptococcus pneumoniae clinical isolates obtained in Canada in 2002Prevalence and molecular analysis of macrolide and fluoroquinolone resistance among isolates of Streptococcus pneumoniae collected during the 2000-2001 PROTEKT US StudyActivities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Serotyping, Antibiotic Susceptibility and Related Risk Factors Aspects of Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy School Students.High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care.
P2860
Q24600215-4938447D-9511-4566-B185-8EC16EE1332FQ24798440-BEB5902C-45B3-43D0-95E6-47D988E99C85Q26996633-99FA59B2-BA50-47B6-860A-AFD1CC3445B0Q30251593-7E7A67FF-07E6-477C-AEC0-69B13D756470Q33246841-A41F384A-C768-432F-9265-E6B4B31B4E40Q33628610-5F2DFCB9-3426-4F19-960F-C91F75F827E8Q33752905-FD91EE11-2A16-4BB9-98A8-E7B270EDF814Q33752944-F338F9B4-A929-47D2-9513-252BA100159AQ33753071-39476EFC-A65E-4D59-BC7D-F8B14FF972FFQ33858998-E6422F0A-41FE-4211-B825-3EF12C865E06Q33883600-B9107E6F-A2D8-4C88-9933-E2FE3B16BAB1Q33938161-927D60A5-1832-420A-8469-DAED912E9854Q34143934-1351ECB5-8651-4305-AB07-1D1B261EEEACQ34230515-945D3629-1597-453A-8D12-5A7169855885Q34951125-21CC5CB5-AAD3-456F-AC6C-7F5721F98821Q35103743-EDD044D1-2028-4E5A-BAD8-C1F510BA198DQ35103781-9200D537-3EDC-46F3-A53E-8AD6D4F1C972Q35105368-DD96AA9A-54FA-47D2-9E33-3E7AF62CD9BCQ35635797-FE2D4838-BEBB-4FEA-AB06-6521A84A496EQ35686847-FA0DB17F-DEE5-4B52-BBD7-7E8ACC9A1EB5Q35784460-265554E3-B0B1-4AB3-BA8C-3D8168FD4484Q36009392-203BF050-AD3A-4D9F-B4EA-F1D87BC3E146Q36009405-B6E9B86F-7C30-48E8-B1EC-714DFD3732ABQ36107922-D9A8D9C7-A1CF-4767-B92F-72A41291576CQ36337074-9261C4A7-D480-4E95-B421-AF533FF6BDABQ36383895-4E59094E-8292-483E-B5FE-046DC289B379Q36487417-81886A06-F921-4103-9484-CF806225F741Q36488221-07337CEA-89A6-4EA2-9FE5-FB6B31FE8400Q36670675-45512B7C-5032-46DC-BDC1-E4203EB5AC93Q36759984-2F4E8C83-3761-4B9A-80E0-BCB33A84BED6Q37120857-62E66D55-8F09-4471-B376-D23379923D71Q37228717-8170B037-8180-4255-91B9-1699D27BFF61Q37263914-B620CA4C-C14C-4617-823C-CE8D915E8176Q37437298-76E9D277-2A10-41F1-99E7-CC02C7F57716Q37488975-9DB6BFA7-6C4A-4314-9EF1-FA81BE700428Q37597579-53615C2D-59EE-4548-9191-2C8D39C67D84Q37734496-C786F800-8FA6-4466-8619-A980B4E77709Q37998398-9C176E6E-8E64-4E3B-B519-13E0549D5225Q38984686-6512AB91-E101-4A63-BD0B-BAFD51354CAAQ39251511-3667DE2C-9717-4A80-8CA8-B30E408E9438
P2860
Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@ast
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@en
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@nl
type
label
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@ast
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@en
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@nl
prefLabel
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@ast
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@en
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@nl
P2093
P356
P1476
Increasing prevalence of antim ...... f the ketolide, telithromycin.
@en
P2093
Arne Rodloff
David Felmingham
Ralf Rene Reinert
Yoichi Hirakata
P356
10.1093/JAC/DKF808
P407
P478
50 Suppl S1
P577
2002-09-01T00:00:00Z